Cardiovascular risk assessment and treatment in systemic lupus erythematosus
With improved treatment modalities and survival rates, patients with systemic lupus erythematosus live longer and their co-morbidities have become more apparent. Of great concern is cardiovascular disease, which has become a leading cause of death. Lupus patients prematurely develop atherosclerosis,...
Saved in:
Published in | Best practice & research. Clinical rheumatology Vol. 23; no. 4; pp. 481 - 494 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.08.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!